Company: NGVT
Filing Date: 2025-12-01
Form Type: 8-K
Source: 0001653477-25-000133
Chunk: 0

Company: Ingevity Corp
Filing Date: 2025-12-01
Form: 8-K
Item: Item 7.01
Chunk 0
---
ITEM 7.01. REGULATION FD DISCLOSURE

On September 3, 2025, Ingevity Corporation, a Delaware corporation ("Ingevity", "the Company") entered into an Asset Purchase Agreement (the "Purchase Agreement") with Mainstream Pine Products, LLC, a Delaware limited liability company ("Purchaser"), pursuant to which Purchaser will purchase substantially all of the assets and assume and acquire certain of the rights and liabilities of Ingevity or its applicable affiliates that relate to or are used in connection with (a) Ingevity's industrial specialties product line (other than Ingevity's lignin dispersant and alternative fatty acid based products, road technologies product line and other businesses and products more fully described in the Purchase Agreement) and (b) Ingevity's North Charleston, South Carolina crude tall oil refinery (the "CTO Refinery") and Ingevity's and its affiliates' operations thereof (collectively, the "Divestiture"). The Divestiture is expected to close by early 2026.

Ingevity previously disclosed the Divestiture and the Asset Purchase Agreement (the "Purchase Agreement") in a Current Report on Form 8-K filed by Ingevity with the Securities and Exchange Commission (the "SEC") on September 3, 2025 (the "Previous Form 8-K"). The foregoing description of the Purchase Agreement and the acquisition does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Purchase Agreement filed as Exhibit 2.1 to the Previous Form 8-K, which is incorporated herein by reference.

In connection with the transaction, the Company determined that the industrial specialties product line and CTO Refinery included within the Divestiture met the criteria to be classified as held for sale and that the sale represents a strategic shift that will have a major effect on Ingevity’s operations and results. Accordingly, for all periods presented, the results of operations of the industrial specialties product line and CTO Refinery, collectively defined above as the Divestiture, are presented as discontinued operations within this Form 8-K.

Ingevity is providing, attached as Exhibit 99.1, unaudited recast Condensed Consolidated Statements of Operations, Segment Operating Results, and certain Non-GAAP Financial Measures for the years ended December 31, 2024 and 2023 as well as the three month periods ended March